Brain gamma-aminobutyric acid and benzodiazepine receptor binding in dialysis encephalopathy.
We measured gamma-aminobutyric acid (GABA) and benzodiazepine binding in autopsied frontal cortex of 8 patients dying with dialysis encephalopathy (DE). No alteration in [3H] GABA binding was observed. However, a mild reduction (-23%, P less than 0.05) of [3H] flunitrazepam-binding density was found in DE cortex. The magnitude of this reduction was similar to that observed in frontal cortex of amygdala-kindled rats [10]. We suggest that a reduction in benzodiazepine receptor number, in combination with markedly reduced GABA concentration in DE cerebral cortex may contribute to some of the clinical features (especially seizures) characteristically observed in this syndrome.
D001570:Benzodiazepinones / Q000378:metabolism; D001927:Brain Diseases / Q000378:metabolism*; D005445:Flunitrazepam / Q000378:metabolism; D005625:Frontal Lobe / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D011963:Receptors, GABA-A / Q000032:analysis* / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects*; D005680:gamma-Aminobutyric Acid / Q000032:analysis*
D001570:Benzodiazepinones; D011963:Receptors, GABA-A; C028513:4'-chlorodiazepam; D005680:gamma-Aminobutyric Acid; D005445:Flunitrazepam